Pricing Log in Create free account

Cardio Diagnostics Holdings, Inc. (CDIO) vs Orgenesis Inc. (ORGS)

Cardio Diagnostics Holdings, Inc. and Orgenesis Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Orgenesis Inc. are of similar size ($5.7M and $5.2M). Orgenesis Inc. grew revenue faster over the last twelve months: 95.3% against −25.1%. Orgenesis Inc. has the higher net margin (−4,653.6% vs −44,312.3%) and the higher return on invested capital (0.00% vs −219.4%). Across the 16 metrics below, Orgenesis Inc. leads on 9 and Cardio Diagnostics Holdings, Inc. on 7.

Valuation

Metric CDIO ORGS Biotechnology median
P/E n/m n/m 8.50
P/S 342.57 0.24 9.71
P/B 0.67 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.10 n/m 0.64
EV/Sales (40.08) 15.71 9.21
Earnings yield (172.78%) (19,183.33%) (33.15%)
Free cash flow yield (116.45%) (6,862.91%) (25.50%)

Profitability

Metric CDIO ORGS Biotechnology median
Gross margin 100.00% (86.28%) 65.16%
Operating margin (44,230.82%) (3,842.32%) 0.00%
Net margin (44,312.33%) (4,653.62%) 0.00%
Free cash flow margin (39,893.15%) (1,675.27%) 0.00%
Return on equity (75.44%) 164.62% (56.36%)
Return on assets (70.62%) (605.73%) (48.04%)
Return on invested capital (219.40%) 0.00% 0.00%

Growth

Metric CDIO ORGS Biotechnology median
Revenue growth (TTM) (25.13%) 95.28% 6.02%
EPS growth (last fiscal year) 60.15% 40.10% 30.26%
Revenue growth, 5-year CAGR — (23.30%) 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDIO ORGS Biotechnology median
Debt to equity 0.00 (0.44) 0.00
Current ratio 17.15 0.03 4.72
Net debt to EBITDA 0.84 (0.42) 0.96

Dividend

Metric CDIO ORGS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CDIO ORGS Biotechnology median
Market cap 5.21m 5.68m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack